Active, not recruiting
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
NCT05374603
- Conditions
- Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- Research Site Beijing, China
- Research Site Beijing, China
- Research Site Beijing, China
- Research Site Changsha, China